Nifty
Sensex
:
:
17853.20
60048.47
30.25 (0.17%)
163.11 (0.27%)

Pharmaceuticals & Drugs - API

Rating :
59/99

BSE: 532488 | NSE: DIVISLAB

5108.55
24-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  5235.35
  •  5254.00
  •  5092.00
  •  5212.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  350328
  •  18100.59
  •  5271.65
  •  3015.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 135,436.76
  • 66.09
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 133,281.08
  • 0.39%
  • 13.75

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.95%
  • 1.39%
  • 8.81%
  • FII
  • DII
  • Others
  • 20.6%
  • 16.18%
  • 1.07%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.10
  • 11.39
  • 12.11

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.26
  • 14.61
  • 8.84

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.04
  • 13.35
  • 13.62

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.04
  • 36.72
  • 47.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.28
  • 7.38
  • 8.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.76
  • 25.77
  • 31.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
1,960.64
1,730.47
13.30%
1,788.19
1,389.71
28.67%
1,701.44
1,396.26
21.86%
1,749.30
1,445.57
21.01%
Expenses
1,108.59
1,030.39
7.59%
1,071.93
945.26
13.40%
1,010.23
902.36
11.95%
1,008.16
955.01
5.57%
EBITDA
852.05
700.08
21.71%
716.26
444.45
61.16%
691.21
493.90
39.95%
741.14
490.56
51.08%
EBIDTM
43.46%
40.46%
40.05%
31.98%
40.63%
35.37%
42.37%
33.94%
Other Income
35.97
17.33
107.56%
23.52
76.73
-69.35%
19.32
41.67
-53.64%
13.64
47.03
-71.00%
Interest
0.28
0.23
21.74%
0.21
0.44
-52.27%
0.27
1.55
-82.58%
0.16
3.79
-95.78%
Depreciation
73.26
56.20
30.36%
70.08
49.78
40.78%
68.18
46.70
46.00%
61.13
45.93
33.09%
PBT
814.48
660.98
23.22%
669.49
470.96
42.15%
642.08
487.32
31.76%
693.49
487.87
42.15%
Tax
257.37
168.92
52.36%
167.47
82.73
102.43%
171.46
128.23
33.71%
173.90
131.09
32.66%
PAT
557.11
492.06
13.22%
502.02
388.23
29.31%
470.62
359.09
31.06%
519.59
356.78
45.63%
PATM
28.41%
28.43%
28.07%
27.94%
27.66%
25.72%
29.70%
24.68%
EPS
20.99
18.54
13.21%
18.91
14.63
29.25%
17.73
13.53
31.04%
19.57
13.44
45.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
7,199.57
6,969.40
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
2,144.84
1,863.87
Net Sales Growth
20.76%
29.20%
9.06%
27.10%
-4.25%
7.63%
21.23%
23.02%
18.06%
15.07%
 
Cost Of Goods Sold
2,326.38
2,324.08
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
798.63
761.64
Gross Profit
4,873.19
4,645.32
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
1,346.21
1,102.23
GP Margin
67.69%
66.65%
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
62.77%
59.14%
Total Expenditure
4,198.91
4,108.23
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
1,328.87
1,172.59
Power & Fuel Cost
-
319.15
280.73
248.78
228.73
198.80
180.34
170.82
147.40
131.02
86.13
% Of Sales
-
4.58%
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
6.11%
4.62%
Employee Cost
-
825.76
621.05
542.27
456.06
499.90
361.19
290.42
232.46
197.72
150.85
% Of Sales
-
11.85%
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
9.22%
8.09%
Manufacturing Exp.
-
297.84
258.91
212.96
182.67
169.15
169.42
147.24
121.10
104.85
86.61
% Of Sales
-
4.27%
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
4.89%
4.65%
General & Admin Exp.
-
175.26
148.62
105.30
139.33
88.22
73.91
63.85
51.74
44.15
32.47
% Of Sales
-
2.51%
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
2.06%
1.74%
Selling & Distn. Exp.
-
124.03
85.36
73.08
64.02
67.48
56.04
51.93
44.22
51.29
53.63
% Of Sales
-
1.78%
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
2.39%
2.88%
Miscellaneous Exp.
-
42.11
68.00
65.63
23.87
59.65
11.80
11.18
5.69
1.21
53.63
% Of Sales
-
0.60%
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
0.06%
0.07%
EBITDA
3,000.66
2,861.17
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
815.97
691.28
EBITDA Margin
41.68%
41.05%
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
38.04%
37.09%
Other Income
92.45
62.56
189.63
155.63
113.44
74.89
97.44
44.70
70.60
44.81
56.05
Interest
0.92
2.10
7.14
4.68
2.37
3.36
4.74
2.88
2.96
2.59
4.61
Depreciation
272.65
255.59
186.24
168.90
142.49
123.33
118.18
136.00
92.12
76.95
62.08
PBT
2,819.54
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
Tax
770.20
681.75
442.92
502.33
354.32
334.92
267.06
220.56
217.58
179.23
147.36
Tax Rate
27.32%
25.57%
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
22.94%
21.65%
PAT
2,049.34
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
PAT before Minority Interest
2,049.34
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
28.46%
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
28.07%
28.61%
PAT Growth
28.39%
44.15%
1.76%
54.24%
-17.30%
-5.81%
32.21%
10.11%
28.46%
12.89%
 
EPS
77.19
74.74
51.85
50.95
33.03
39.94
42.40
32.07
29.13
22.67
20.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
9,294.61
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
2,500.60
2,131.52
Share Capital
53.09
53.09
53.09
53.09
53.09
53.09
26.55
26.55
26.55
26.55
Total Reserves
9,241.52
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
2,474.05
2,104.98
Non-Current Liabilities
363.94
294.57
991.38
1,768.91
1,411.75
85.17
841.57
650.05
469.75
71.35
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.47
1.05
1.55
2.10
2.56
Long Term Provisions
25.42
20.52
772.54
1,577.26
1,288.92
11.57
714.30
533.49
388.43
1.65
Current Liabilities
1,728.35
1,820.53
846.75
653.42
659.45
519.50
775.53
627.41
554.45
553.78
Trade Payables
763.20
590.72
492.26
411.21
445.80
232.69
226.87
151.70
160.44
159.54
Other Current Liabilities
340.42
290.09
243.59
175.46
176.63
240.58
203.45
147.80
130.08
135.83
Short Term Borrowings
0.35
33.63
105.60
63.11
35.74
41.42
25.07
16.32
30.51
50.20
Short Term Provisions
624.38
906.09
5.30
3.64
1.28
4.81
320.14
311.58
233.42
208.21
Total Liabilities
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
3,524.80
2,756.65
Net Block
3,703.87
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
908.72
738.42
Gross Block
4,691.86
3,514.25
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
1,338.35
1,092.05
Accumulated Depreciation
987.99
732.40
546.16
377.26
234.76
757.32
644.13
518.50
429.63
353.64
Non Current Assets
4,596.30
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
1,660.69
1,005.71
Capital Work in Progress
710.62
919.69
491.91
119.76
443.57
263.91
218.18
144.48
303.41
181.58
Non Current Investment
0.01
0.01
547.26
0.01
0.01
0.01
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
172.59
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
448.49
83.68
Other Non Current Assets
9.21
5.44
5.36
7.82
8.83
5.80
0.35
0.09
0.07
1.63
Current Assets
6,790.60
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
1,864.11
1,750.95
Current Investments
0.00
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
407.81
477.04
Inventories
2,145.23
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
835.69
678.96
Sundry Debtors
1,676.52
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
723.70
512.00
495.08
Cash & Bank
2,156.03
122.63
115.26
112.46
78.70
73.43
65.22
40.51
40.89
30.94
Other Current Assets
812.82
202.57
142.20
124.98
80.26
62.01
69.89
57.85
67.71
68.93
Short Term Loans & Adv.
684.40
999.77
58.54
43.37
59.59
42.88
54.98
48.16
57.97
63.25
Net Current Assets
5,062.25
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
1,309.66
1,197.16
Total Assets
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80
3,524.80
2,756.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
1,946.93
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
556.75
479.97
338.36
PBT
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
Adjustment
189.29
60.01
83.51
32.19
93.87
60.94
91.24
77.55
59.25
26.87
Changes in Working Capital
-264.08
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
-186.05
-242.47
Cash after chg. in Working capital
2,591.25
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
654.44
465.03
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-644.32
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
-174.47
-126.68
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
75.13
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
-254.54
-204.41
Net Fixed Assets
-968.33
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
-368.08
-284.15
Net Investments
971.35
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
69.23
48.60
Others
72.11
244.84
3.42
34.81
-535.74
-40.44
-3.41
31.90
44.31
31.14
Cash from Financing Activity
-34.89
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
-230.76
-131.11
Net Cash Inflow / Outflow
1,987.17
41.05
22.96
-16.60
13.15
0.33
2.54
3.10
-5.33
2.84
Opening Cash & Equivalents
43.15
2.10
-20.86
-4.26
-17.41
17.62
15.09
11.99
17.32
14.48
Closing Cash & Equivalent
2,030.32
43.15
2.10
-20.86
-4.26
17.95
17.62
15.09
11.99
17.32

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
350.15
275.38
262.09
223.20
201.82
161.73
131.67
111.63
94.20
80.29
ROA
19.07%
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
19.17%
21.20%
ROE
23.90%
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
25.99%
27.15%
ROCE
32.07%
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
33.21%
34.20%
Fixed Asset Turnover
1.70
1.75
1.98
1.88
2.06
1.83
1.70
1.66
1.78
1.90
Receivable days
80.91
87.17
80.35
89.33
79.19
77.83
85.12
88.42
85.08
83.45
Inventory Days
104.98
123.02
115.23
124.56
112.34
113.70
121.69
126.52
127.96
121.31
Payable days
59.72
54.82
52.21
60.15
47.14
35.06
33.55
36.16
42.47
42.66
Cash Conversion Cycle
126.17
155.38
143.37
153.75
144.39
156.47
173.26
178.78
170.58
162.09
Total Debt/Equity
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
Interest Cover
1270.54
255.83
397.38
520.55
416.28
294.75
373.59
336.24
302.96
148.53

News Update:


  • Divi’s Laboratories reports 13% rise in Q1 consolidated net profit
    9th Aug 2021, 12:21 PM

    Total consolidated income of the company increased by 14.24% at Rs 1996.61 crore for Q1FY22

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.